Buckingham Strategic Wealth’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
$548K Sell
14,243
-478
-3% -$18.4K 0.01% 447
2024
Q1
$631K Sell
14,721
-1,381
-9% -$59.2K 0.01% 415
2023
Q4
$597K Sell
16,102
-829
-5% -$30.7K 0.01% 412
2023
Q3
$614K Buy
16,931
+448
+3% +$16.2K 0.01% 380
2023
Q2
$587K Buy
16,483
+8,131
+97% +$290K 0.01% 387
2023
Q1
$293K Hold
8,352
0.01% 487
2022
Q4
$293K Sell
8,352
-3,656
-30% -$128K 0.01% 489
2022
Q3
$353K Sell
12,008
-292
-2% -$8.58K 0.01% 437
2022
Q2
$669K Buy
12,300
+59
+0.5% +$3.21K 0.01% 316
2022
Q1
$666K Sell
12,241
-1,035
-8% -$56.3K 0.01% 316
2021
Q4
$732K Buy
13,276
+830
+7% +$45.8K 0.01% 301
2021
Q3
$594K Buy
12,446
+467
+4% +$22.3K 0.01% 324
2021
Q2
$596K Buy
11,979
+1,363
+13% +$67.8K 0.01% 318
2021
Q1
$474K Buy
10,616
+173
+2% +$7.72K 0.02% 341
2020
Q4
$480K Buy
10,443
+2,133
+26% +$98K 0.03% 322
2020
Q3
$391K Buy
8,310
+729
+10% +$34.3K 0.03% 309
2020
Q2
$387K Sell
7,581
-3,107
-29% -$159K 0.04% 266
2020
Q1
$506K Buy
10,688
+4,393
+70% +$208K 0.05% 248
2019
Q4
$370K Buy
6,295
+197
+3% +$11.6K 0.04% 307
2019
Q3
$325K Buy
6,098
+855
+16% +$45.6K 0.04% 309
2019
Q2
$262K Buy
+5,243
New +$262K 0.03% 366
2018
Q1
Sell
-5,330
Closed -$236K 328
2017
Q4
$236K Buy
+5,330
New +$236K 0.05% 274
2017
Q3
Sell
-4,006
Closed -$216K 295
2017
Q2
$216K Buy
4,006
+8
+0.2% +$431 0.05% 273
2017
Q1
$211K Buy
+3,998
New +$211K 0.06% 237
2016
Q2
Sell
-4,205
Closed -$213K 254
2016
Q1
$213K Buy
4,205
+33
+0.8% +$1.67K 0.07% 205
2015
Q4
$210K Buy
+4,172
New +$210K 0.07% 184